These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3661064)

  • 1. The rapid diagnosis of sensitivity or resistance to dopamine agonists with depot bromocriptine.
    Grossman A; Wass JA; Besser M
    Acta Endocrinol (Copenh); 1987 Oct; 116(2):275-81. PubMed ID: 3661064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral prednisolone supplement abolishes the acute adverse effects following initiation of depot bromocriptine therapy.
    Jenkins PJ; Jain A; Jones SL; Besser GM; Grossman AB
    Clin Endocrinol (Oxf); 1996 Oct; 45(4):447-51. PubMed ID: 8959084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depot-bromocriptine treatment for prolactinomas and acromegaly.
    Grossman A; Ross R; Wass JA; Besser GM
    Clin Endocrinol (Oxf); 1986 Feb; 24(2):231-8. PubMed ID: 3708874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinagolide efficacy and tolerability in hyperprolactinaemic patients who are resistant to or intolerant of bromocriptine.
    Vilar L; Burke CW
    Clin Endocrinol (Oxf); 1994 Dec; 41(6):821-6. PubMed ID: 7889620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cabergoline. A review of its pharmacological properties and therapeutic potential in the treatment of hyperprolactinaemia and inhibition of lactation.
    Rains CP; Bryson HM; Fitton A
    Drugs; 1995 Feb; 49(2):255-79. PubMed ID: 7729332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of CV205-502 in patients with hyperprolactinaemia intolerant and/or resistant to bromocriptine.
    Razzaq R; O'Halloran DJ; Beardwell CG; Shalet SM
    Horm Res; 1993; 39(5-6):218-22. PubMed ID: 7906243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute and long-term effects of once-daily oral bromocriptine and a new long-acting non-ergot dopamine agonist, quinagolide, in the treatment of hyperprolactinemia: a double-blind study.
    Verhelst JA; Froud AL; Touzel R; Wass JA; Besser GM; Grossman AB
    Acta Endocrinol (Copenh); 1991 Oct; 125(4):385-91. PubMed ID: 1683503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lactation inhibition by a single injection of a new depot-bromocriptine.
    Kremer JA; Rolland R; van der Heijden PF; Schellekens LA; Vosmar MB; Lancranjan I
    Br J Obstet Gynaecol; 1990 Jun; 97(6):527-32. PubMed ID: 2378830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quinagolide--a valuable treatment option for hyperprolactinaemia.
    Barlier A; Jaquet P
    Eur J Endocrinol; 2006 Feb; 154(2):187-95. PubMed ID: 16452531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of CV 205-502 in hyperprolactinaemic patients intolerant of bromocriptine.
    Newman CB; Hurley AM; Kleinberg DL
    Clin Endocrinol (Oxf); 1989 Oct; 31(4):391-400. PubMed ID: 2576397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Parenteral, depot and repeatable forms of Parlodel LAR bromocriptine in the treatment of hyperprolactinemia syndrome. Comparison with oral Parlodel].
    Dolecek R; Lancranjanová I; Putz Z; Vavros D; Závada M
    Cas Lek Cesk; 1993 Feb; 132(3):81-5. PubMed ID: 8458069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative review of the tolerability profiles of dopamine agonists in the treatment of hyperprolactinaemia and inhibition of lactation.
    Webster J
    Drug Saf; 1996 Apr; 14(4):228-38. PubMed ID: 8713691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CV 205-502, a new dopamine agonist, versus bromocriptine in the treatment of hyperprolactinaemia.
    van der Heijden PF; de Wit W; Brownell J; Schoemaker J; Rolland R
    Eur J Obstet Gynecol Reprod Biol; 1991 Jul; 40(2):111-8. PubMed ID: 1676973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a repeatable depot-bromocriptine preparation(Parlodel LAR) for the treatment of acromegaly.
    Plöckinger U; Quabbe HJ
    J Endocrinol Invest; 1991 Dec; 14(11):943-8. PubMed ID: 1806612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current treatment issues in female hyperprolactinaemia.
    Crosignani PG
    Eur J Obstet Gynecol Reprod Biol; 2006 Apr; 125(2):152-64. PubMed ID: 16288952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new oral slow release form of bromocriptine, Parlodel SRO, in the chronic treatment of 26 hyperprolactinemic patients.
    Gianola D; Pedroncelli A; Montini M; Tengattini F; Pagani MD; Cortesi L; Cappi MP; Gherardi F; Lancranjan I; Pagani G
    Gynecol Endocrinol; 1991 Sep; 5(3):213-6. PubMed ID: 1776507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of a new long-acting injectable form of bromocriptine in hyperprolactinaemic patients.
    Pagani MD; Tengattini F; Montini M; Pagani G; Pedroncelli A; Gianola D; Gherardi F; Mazzocchi N; Cortesi L; Lancranjan I
    Clin Endocrinol (Oxf); 1992 Apr; 36(4):369-74. PubMed ID: 1424170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of short-term metformin treatment on plasma prolactin levels in bromocriptine-treated patients with hyperprolactinaemia and impaired glucose tolerance: a pilot study.
    Krysiak R; Okrzesik J; Okopien B
    Endocrine; 2015 May; 49(1):242-9. PubMed ID: 25239203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-acting repeatable bromocriptine in the treatment of patients with microprolactinoma intolerant or resistant to oral dopaminergics.
    Espinós JJ; Rodríguez-Espinosa J; Webb SM; Calaf-Alsina J
    Fertil Steril; 1994 Nov; 62(5):926-31. PubMed ID: 7926136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients.
    Verhelst J; Abs R; Maiter D; van den Bruel A; Vandeweghe M; Velkeniers B; Mockel J; Lamberigts G; Petrossians P; Coremans P; Mahler C; Stevenaert A; Verlooy J; Raftopoulos C; Beckers A
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2518-22. PubMed ID: 10404830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.